We are live on ! Find out more
AC

Amia Capital Portfolio holdings

AUM $32.1M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+13.17%
1 Year Est. Return
+0.56%
3 Year Est. Return
+30.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$343M
AUM Growth
–
Cap. Flow
+$327M
Cap. Flow %
95.33%
Top 10 Hldgs %
88.26%
Holding
41
New
41
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
+$70.6M
2
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$66.2M
3
GRFS
Grifois
GRFS
+$47M
4
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
+$44.1M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$17.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 26.19%
2 Energy 3.72%
3 Communication Services 3.4%
4 Materials 3.08%
5 Consumer Discretionary 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYOK
26
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$992K 0.29%
+13,616
New +$826K
ICPT
27
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$951K 0.28%
+7,678
New +$687K
BOLD
28
DELISTED
Audentes Therapeutics, Inc
BOLD
$910K 0.27%
+15,205
New +$571K
MYOV
29
DELISTED
Myovant Sciences Ltd.
MYOV
$830K 0.24%
+53,508
New +$539K
NKTR icon
30
Nektar Therapeutics
NKTR
$2.39B
$583K 0.17%
+1,802
New +$523K
EXEL icon
31
Exelixis
EXEL
$13.9B
$530K 0.15%
+30,096
New +$510K
CRSP icon
32
CRISPR Therapeutics
CRSP
$4.58B
$513K 0.15%
+8,427
New +$460K
MGNX icon
33
MacroGenics
MGNX
$235M
$486K 0.14%
+44,648
New +$442K
AKCA
34
DELISTED
Akcea Therapeutics Inc
AKCA
$478K 0.14%
+28,217
New +$525K
QTTB icon
35
Q32 Bio
QTTB
$450M
$426K 0.12%
+1,144
New +$328K
UBS icon
36
UBS Group
UBS
$170B
$325K 0.09%
+25,840
New +$307K
SGMO
37
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$311K 0.09%
+37,112
New +$341K
GILD icon
38
Gilead Sciences
GILD
$161B
$308K 0.09%
+4,746
New +$309K
BMY icon
39
Bristol-Myers Squibb
BMY
$127B
$277K 0.08%
+4,321
New +$247K
VYGR icon
40
Voyager Therapeutics
VYGR
$187M
$275K 0.08%
+19,683
New +$286K
WVE icon
41
Wave Life Sciences
WVE
$1.12B
$165K 0.05%
+20,646
New +$506K
1
2

Similar funds

QI
Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return
SAM
Sandbar Asset Management London, United Kingdom $30.5M AUM 46.07% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
NLG
New Legacy Group New York $36.6M AUM 36.77% 1-Year Est. Return
BEVI
Braemar Energy Ventures III New York $37.9M AUM 66.45% 1-Year Est. Return
BGDR
BC Gestao de Recursos Sao Paulo, Brazil $38.2M AUM
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return

Amia Capital's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Amia Capital, which disclosed 41 positions worth $343M. Its ten largest holdings account for 88% of the portfolio.

Its largest position is Liberty Media Corporation Series A Liberty SiriusXM Common Stock: 2,135,607 shares worth $74.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, followed by Energy and Communication Services.

  • Amia Capital's largest Q4 2019 buy was Liberty Media Corporation Series A Liberty SiriusXM Common Stock: 2,135,607 shares worth $74.6M.
  • Amia Capital's ten largest holdings make up 88% of its $343M portfolio in Q4 2019.
  • Amia Capital disclosed 41 positions in Q4 2019, its first 13F filing on record.

Based on Amia Capital's 13F filing for Q4 2019, filed 13 Feb 2020.